Aegeria Soft Tissue Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Investors
  • 1

Aegeria Soft Tissue General Information

Description

Developer of tissue reconstruction technologies. The company develops tissue reconstruction technologies that provides a natural structure to mimic normal soft tissue and promote new fat tissue growth.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 7 Street, Paul Street
  • Suite 1660
  • Baltimore, MD 21202
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aegeria Soft Tissue Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 01-Oct-2011 Completed Startup
1. Accelerator/Incubator 01-Jan-2011 Completed Startup
To view Aegeria Soft Tissue’s complete valuation and funding history, request access »

Aegeria Soft Tissue Executive Team (4)

Name Title Board Seat Contact Info
Alessandro Ovi Co-Founder
Jennifer Elisseeff Ph.D Co-Founder
Lee Marks Co-Founder
Patrick Byrne MD Chief Medical Officer
To view Aegeria Soft Tissue’s complete executive team members history, request access »

Aegeria Soft Tissue Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view Aegeria Soft Tissue’s complete investors history, request access »